SkyDeck

CRISPR Wars

UC Berkeley’s Jennifer Doudna has chalked up another award for her discovery of the revolutionary CRISPR-Cas9 gene-editing tool. The Kavli Prize in nanoscience is worth $1 million and will be shared among the three recipients, which includes Doudna’s collaborator, Emmanuelle Charpentier of the Max Planck Institute.

The robot and I met at the southwest corner of Center and Shattuck. It was 3 p.m. on a Wednesday, and the streets were bustling. The robot was small and boxy, something like a cooler on wheels. I knelt down at what I presumed was the robot’s front end. It winked a pixilated eye.

Following instructions I’d received in advance, I raised a hand and flashed an “okay” sign. The robot emitted a pleasant dinging sound and a hatch on top slowly opened. I reached in and removed a grease-stained paper bag. Inside were two slices of warm pizza.

Broken hip announcements were a dark opera as I entered adulthood. Both parents. Then the parents of many of my friends and the parents of their friends’ friends as we marched toward middle age. For each of the afflicted, it was the last stumble toward the grave. For their offspring, who had tumbled through the tear gas of the Vietnam era, it was strange to witness: falling down, then pneumonia, confusion, intestinal bleeding, bladder infections, dementia, stroke, and within a year or at most two, the tomb.

SkyDeck, UC Berkeley’s start-up accelerator program, is housed on the top floor of the tallest building in downtown Berkeley. All four walls of the 10,000 square-foot penthouse have floor-to-ceiling windows, offering up a 360-degree view. This is where Cal’s fledgling entrepreneurs come for free office space and guidance while preparing to launch their product or service. They have six months to a year up here with SkyDeck, and then it’s time to jump out of the nest.

Whatever wariness has accompanied the collaboration between public universities and private sector profit-seeking, that horse appears well out of the barn, foaming at the mouth and galloping madly for the horizon. At UC Berkeley, academic/corporate “incubators” and “accelerators” are all the rage. Supporters focus on the upside: Creative researchers are able to launch start-ups that produce spookily cool products and generate gigabucks in the process—and may even embody the maxim to do well by doing good.